How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Famed short seller Andrew Left faces the possibility of decades behind bars after being found guilty of using disingenuous social media posts to manipulate stocks, in a landmark case that threatens to ...
A U.S. jury found prominent investor Andrew Left guilty of securities fraud on Monday, the Justice Department said, in a blow to a divisive cohort of short sellers who have for years goaded public ...
"The Frustration Became a Design Brief": Why an Architect Left 20 Years of Practice to Map the World
Åvontuura Founder Karl van Es with his Architecture Guide to Toronto Karl van Es spent twenty years as a practicing architect before walking away to solve a problem every architect faces: the ...
LOS ANGELES—Andrew Left earned fame and fortune by researching companies, accusing them of fraud and betting their stock price would fall. On Monday, a federal jury convicted him of securities fraud, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
An Editor at Large: A U.S.-China conflict would be perilous for both nations, and the ultimate outcome isn’t inevitable. Photo: Ann Wang/Reuters/Alamy Stock Image/Brendan Smialowski/AFP/Getty Images ...
Jury convicts Left of securities fraud, acquits on four counts, sentencing set for August 31 Prosecutors allege Left manipulated markets via media, profiting from misleading stock calls Legal experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results